A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

書誌詳細
第一著者:	Islam, Saidul
その他の著者:	Sharmin, Shahana
フォーマット:	学位論文
言語:	English
出版事項:	Brac University 2022
主題:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
オンライン･アクセス:	http://hdl.handle.net/10361/17308

類似資料

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
著者:: Karim, Azrin
出版事項: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Flora, Sanzida Alam
出版事項: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
著者:: Meem, Manila
出版事項: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
著者:: Alam, Tahera
出版事項: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
著者:: Jahan, Nusrat
出版事項: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
著者:: Ahmed, Nafisa
出版事項: (2023)

Immunotherapy in the Management of Lung Cancer
著者:: Tasnim, Humayra
出版事項: (2022)

A review on triple-negative breast cancer and its potential treatment
著者:: Niasa, Jannatul Ferdous
出版事項: (2023)

Stem cells as therapeutic carrier in cancer treatment
著者:: Anika, Mysha Yeasmin
出版事項: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
著者:: Hasan, Amit
出版事項: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
著者:: Chakraborty, Anuradha
出版事項: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
著者:: Khan, Muidul Hasan
出版事項: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
著者:: Roy, Hredita
出版事項: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
著者:: Emon, Kamrul Hasan
出版事項: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
著者:: Mirza, Maisa Tasnim
出版事項: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
著者:: Khan, Rezia Nowrin
出版事項: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
著者:: Nuha, Nabiha Tahsin
出版事項: (2024)

Role of statins as antagonists of SPARC in gastric cancer
著者:: Shahmat, Rad
出版事項: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
著者:: Sorno, Rubina Haque
出版事項: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
著者:: Ratu, Tabassum
出版事項: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
著者:: Choki, Kinley
出版事項: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
著者:: Razna, Amrin Islam
出版事項: (2019)

A comprehensive review on drug repurposing in cancer treatment
著者:: Sarkar, Onusree
出版事項: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
著者:: Mahaleka, Aarshi
出版事項: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
著者:: Shaikat, Mahdi Mubin
出版事項: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
著者:: Hasan, Sakib
出版事項: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
著者:: Nawar, Anika
出版事項: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
著者:: Deeba, Maliha Tasnim
出版事項: (2018)

Targeting BRAFV600E in the treatment of CRC
著者:: Roja, Mashwiyat Samrin
出版事項: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
著者:: Alam, Kazi Tasnuva
出版事項: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
著者:: Rahman, Sanjida
出版事項: (2024)

Biosimilar in lymphoma treatment
著者:: Tanisha, Mehrin Haque
出版事項: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
著者:: Khondokar, Faiza
出版事項: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
著者:: Islam, Nahidul
出版事項: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
著者:: Beruni, Sajid Mahmud Al
出版事項: (2022)

Oncogenes: new targets in cancer treatment
著者:: Chowdhury, Waseka Shams
出版事項: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
著者:: Muntaha, Habibatul
出版事項: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
著者:: Haque, Mushfiqul
出版事項: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Karim, Samia Binte
出版事項: (2024)